Barriers to Coronavirus Disease 19 vaccination in patients with obesity

Am J Surg. 2023 Feb;225(2):357-361. doi: 10.1016/j.amjsurg.2022.08.021. Epub 2022 Sep 1.

Abstract

Background: Patients with obesity are at a high risk of severe disease and death from Coronavirus Disease 2019 (COVID-19). Vaccination offers a safe and effective means of reducing this risk. The rate of COVID-19 vaccine refusal in patients with obesity is unknown.

Methods: Patients with obesity were administered validated questionnaires assessing COVID-19 fear, general vaccine hesitancy, and COVID-19-specific vaccine hesitancy.

Results: 507 participants completed the study. COVID-19 vaccine hesitancy was high: Fifteen percent of patients refused COVID-19 vaccine. Hesitancy related to other vaccines was also high: Eight percent of patients refused a vaccine in the past, and 15% delayed a vaccine. Fear of side effects and doubts regarding effectiveness were the most common reasons for vaccine refusal.

Conclusions: Despite high risk for complications, vaccine hesitancy is high among patients with obesity. Targeted public health interventions are critical to reduce vaccine hesitancy and improve vaccination rates.

Keywords: COVID-19; Obesity; Vaccination; Vaccine hesitancy.

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • Obesity / complications
  • Patients
  • Vaccination

Substances

  • COVID-19 Vaccines